Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Fagiuoli

Showing results (41-50 of 90) with videos related to

Pageof 9
Sort By:
The Journal of the Oklahoma State Medical Association|June 1, 1994
Parental and medical over-administration of acetaminophen causing lethal hepatotoxicity in a 10-year-oldA Nadir, R McFadden, J Griggs, et al.
The Journal of the Oklahoma State Medical Association|April 1, 1995
The Oklahoma-Pittsburgh experience with interferon alpha in the treatment of HCV diseaseD H Van Thiel, L Friedlander, S Fagiuoli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infectionA Buda, A Caforio, F Calabrese, et al.
Journal of Hepatology|July 4, 2001
Histological features after liver transplantation in alcoholic cirrhoticsP Burra, D Mioni, A Cecchetto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
HBV and HCV infections in heart transplant recipientsS Fagiuoli, F Minniti, S Pevere, et al.
Infection|November 19, 2011
Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?M Milan, S Boninsegna, L Scribano, et al.
Journal of Hepatology|March 1, 1994
Response to interferon alpha therapy is influenced by the iron content of the liverD H Van Thiel, L Friedlander, S Fagiuoli, et al.
Journal of Hepatology|March 1, 1992
Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical featuresF Farinati, S Fagiuoli, N De Maria, et al.
The Journal of the Oklahoma State Medical Association|May 1, 1994
Rheumatoid arthritis: a complication of interferon therapyF Nadir, S Fagiuoli, H I Wright, et al.
Hepato-Gastroenterology|November 1, 1995
gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis CD H Van Thiel, L Friedlander, P Malloy, et al.
Pageof 9

Showing results (41-50 of 90) with videos related to

Sort By:
Pageof 9
The Journal of the Oklahoma State Medical Association|June 1, 1994
Parental and medical over-administration of acetaminophen causing lethal hepatotoxicity in a 10-year-oldA Nadir, R McFadden, J Griggs, et al.
The Journal of the Oklahoma State Medical Association|April 1, 1995
The Oklahoma-Pittsburgh experience with interferon alpha in the treatment of HCV diseaseD H Van Thiel, L Friedlander, S Fagiuoli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 9, 2000
Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infectionA Buda, A Caforio, F Calabrese, et al.
Journal of Hepatology|July 4, 2001
Histological features after liver transplantation in alcoholic cirrhoticsP Burra, D Mioni, A Cecchetto, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|July 13, 2001
HBV and HCV infections in heart transplant recipientsS Fagiuoli, F Minniti, S Pevere, et al.
Infection|November 19, 2011
Viral kinetics during the first weeks of pegylated interferon and ribavirin treatment can identify patients at risk of relapse after its discontinuation: new strategies for such patients?M Milan, S Boninsegna, L Scribano, et al.
Journal of Hepatology|March 1, 1994
Response to interferon alpha therapy is influenced by the iron content of the liverD H Van Thiel, L Friedlander, S Fagiuoli, et al.
Journal of Hepatology|March 1, 1992
Anti-HCV positive hepatocellular carcinoma in cirrhosis. Prevalence, risk factors and clinical featuresF Farinati, S Fagiuoli, N De Maria, et al.
The Journal of the Oklahoma State Medical Association|May 1, 1994
Rheumatoid arthritis: a complication of interferon therapyF Nadir, S Fagiuoli, H I Wright, et al.
Hepato-Gastroenterology|November 1, 1995
gamma-Glutamyl transpeptidase as a response predictor when using alpha-interferon to treat hepatitis CD H Van Thiel, L Friedlander, P Malloy, et al.
Pageof 9